“…5 In addition, SP-D enhances their chemotactic, phagocytic, and oxidative properties and interacts with phagocytic cells, such as macrophages and neutrophils. 6 SP-D also modifies allergic responses in that it reduces the activation of basophils, 7 mast cells, 8 and eosinophils 9 while regulating the release of transforming growth factor-b, 10 IL-10, 11 and IL-12 12 and reducing concentrations of IL-2. 13 In allergen challenge models, exogenous SP-D inhibits allergen-induced T lymphocyte proliferation and hypersensitivity, 12 inducing a shift from a type 2 to type 1 cytokine response, and decreases induced airway remodeling.…”